Nipah virus (NiV) and respiratory syncytial virus (RSV) possess two surface glycoproteins involved in cellular attachment and membrane fusion. both of which are potential targets for vaccines. The majority of vaccine development is focused on the attachment (G) protein of NiV. which is the immunodominant target. https://www.jmannino.com/special-deal-A-Magazine-Curated-By-Sacai-quick-pick/